Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127472111 | 12747211 | 1 | I | 20160906 | 20160915 | 20160915 | EXP | PT-MYLANLABS-2016M1038938 | MYLAN | DANIEL CARVALHO ET AL. AS ESTEREOTIPIAS INIBEM AS CRISES EPILEPTICAS?. REVISTAS MEDICAS PORTUGUSES. 2016;16 (1):173 | 0.00 | Y | 0.00000 | 20160915 | MD | PT | PT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127472111 | 12747211 | 1 | PS | LAMOTRIGINE. | LAMOTRIGINE | 1 | Unknown | UNK | U | U | 76630 | ||||||||
| 127472111 | 12747211 | 2 | SS | LEVETIRACETAM. | LEVETIRACETAM | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 127472111 | 12747211 | 3 | SS | TOPIRAMATE. | TOPIRAMATE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 127472111 | 12747211 | 4 | SS | VALPROIC ACID. | VALPROIC ACID | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 127472111 | 12747211 | 5 | SS | PHENYTOIN. | PHENYTOIN | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 127472111 | 12747211 | 6 | SS | CLORAZEPIC ACID | CLORAZEPIC ACID | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 127472111 | 12747211 | 7 | SS | CLOBAZAM | CLOBAZAM | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 127472111 | 12747211 | 8 | SS | PHENOBARBITAL. | PHENOBARBITAL | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127472111 | 12747211 | 1 | Epilepsy |
| 127472111 | 12747211 | 2 | Epilepsy |
| 127472111 | 12747211 | 3 | Epilepsy |
| 127472111 | 12747211 | 4 | Epilepsy |
| 127472111 | 12747211 | 5 | Epilepsy |
| 127472111 | 12747211 | 6 | Epilepsy |
| 127472111 | 12747211 | 7 | Epilepsy |
| 127472111 | 12747211 | 8 | Epilepsy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127472111 | 12747211 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127472111 | 12747211 | Atrophy | |
| 127472111 | 12747211 | Condition aggravated | |
| 127472111 | 12747211 | Excessive eye blinking | |
| 127472111 | 12747211 | Muscle spasms | |
| 127472111 | 12747211 | Paroxysmal choreoathetosis | |
| 127472111 | 12747211 | Salivary hypersecretion | |
| 127472111 | 12747211 | Seizure | |
| 127472111 | 12747211 | Stereotypy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |